ArticleAddictive behaviors2015
Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists.
Article in Addictive behaviors, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Identifying best modelling practices for tobacco control policy simulations: a systematic review and a novel quality assessment framework.Tobacco control · 2023Pooled it
- Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT.Health technology assessment (Winchester, England) · 2023Pooled it
- Community pharmacy personnel interventions for smoking cessation.The Cochrane database of systematic reviews · 2019Pooled it
- Model-based economic evaluations in smoking cessation and their transferability to new contexts: a systematic review.Addiction (Abingdon, England) · 2017Pooled it
- An economic analysis of Native CHOICES.Journal of substance use and addiction treatment · 2026Trial
- A community pharmacist-led smoking cessation intervention using a smartphone app (PharmQuit): A randomized controlled trial.PloS one · 2022Trial
- It is Time to Include Cost-Effectiveness in CME Outcomes Measurement.Journal of CME · 2025Article
- Lessons from Cost-Effectiveness Analysis of Smoking Cessation Programs for Cancer Patients.Current oncology (Toronto, Ont.) · 2022Review
- Attitudes of staff towards smoke-free environments in psychiatric hospitals in Germany.Tobacco induced diseases · 2022Article
- Doctors' smoking control knowledge, attitudes and practices: a cross-sectional study conducted in Shandong Province, China.BMC public health · 2021Article
- Factors Impacting on Development and Implementation of Training Programs for Health Professionals to Deliver Brief Interventions, with a Focus on Programs Developed for Indigenous Clients: A Literature Review.International journal of environmental research and public health · 2020Review
- Local Marketing of a National Texting-Based Smoking Cessation Program: Is It Cost Effective?Frontiers in public health · 2020Article
- Impact of a Novel Smartphone App (CureApp Smoking Cessation) on Nicotine Dependence: Prospective Single-Arm Interventional Pilot Study.JMIR mHealth and uHealth · 2019Article
- Cost-effectiveness analysis of smoking cessation interventions using cell phones in a low-income population.Tobacco control · 2019Article
- Estimates of costs for modelling return on investment from smoking cessation interventions.Addiction (Abingdon, England) · 2018Article
- Effect of a smoking cessation educational intervention on knowledge and confidence of pharmacy students versus community leaders.Pharmacy practiceArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAlthough smoking-cessation interventions typically focus directly on patients, this paper conducts an economic evaluation of a novel smoking-cessation intervention focused on training physicians and/or pharmacists to use counseling techniques that would decrease smoking rates at a reasonable cost. PURPOSE: To evaluate the cost-effectiveness of interventions that train physicians and/or pharmacists to counsel their patients on smoking-cessation techniques.
methodsUsing decision-analytic modeling, we compared four strategies for smoking-cessation counseling education: training only physicians, training only pharmacists, training both physicians and pharmacists (synergy strategy), and training neither physicians nor pharmacists (i.e., no specialized training, which is the usual practice). Short-term outcomes were based on results from a clinical trial conducted in 16 communities across the Houston area; long-term outcomes were calculated from epidemiological data. Short-term outcomes were measured using the cost per quit, and long-term outcomes were measured using the cost per quality-adjusted life-year (QALY). Cost data were taken from institutional sources; both costs and QALYs were discounted at 3%.
resultsTraining both physicians and pharmacists added 0.09 QALY for 45-year-old men. However, for 45-year-old women, the discounted quality-adjusted life expectancy only increased by 0.01 QALY when comparing the synergy strategy to no intervention. The incremental cost-effectiveness ratio (ICER) of the synergy strategy with respect to the non-intervention strategy was US$868/QALY for 45-year-old men and US$8953/QALY for 45-year-old women. The results were highly sensitive to the quit rates and community size.
conclusionSynergistic educational training for physicians and pharmacists could be a cost-effective method for smoking cessation in the community.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.